港股市场速览：大盘再创新高，电子医药居前

Investment Rating - The report maintains an "Outperform" rating for the Hong Kong stock market [4] Core Viewpoints - The overall market has reached new highs, with notable performance in the electronic and pharmaceutical sectors [1] - The Hang Seng Index increased by 1.7%, while the Hang Seng Composite Index rose by 2.3% [1] - Mid-cap stocks outperformed small-cap and large-cap stocks, with a 4.0% increase in the Hang Seng Midcap Index [1] - Among the sector indices, the strongest performers included Defense and Military (+8.8%), Electronics (+8.0%), and Pharmaceuticals (+7.5%) [1] Summary by Sections Market Performance - The Hang Seng Index's valuation increased by 2.3% to 11.6x, and the Hang Seng Composite Index's valuation rose by 2.5% to 11.9x [2] - The strongest valuation increases were seen in the Hang Seng Biotechnology Index (+6.0% to 27.9x) [2] - 22 sectors saw valuation increases, while 6 sectors experienced declines [2] Earnings Expectations - The Hang Seng Index's EPS (Earnings Per Share) is expected to grow by 0.1%, with the Hang Seng Composite Index also seeing a 0.1% increase [3] - The largest upward revision in EPS was for the Hang Seng Automotive Index (+1.5%), while the Hang Seng Consumer Index saw the largest downward revision (-2.2%) [3] - 19 sectors had upward EPS revisions, while 10 sectors had downward revisions [3]